# A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

> **NCT04141228** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 28000 (actual)

## Conditions studied

- Venous Thromboembolism (VTE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04141228
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-29
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-05-31
- **Target enrollment:** 28000 (ACTUAL)
- **Last updated:** 2019-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04141228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04141228, "A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04141228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*